Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.9765
-0.0150 (-1.51%)
At close: Oct 30, 2026, 4:00 PM EDT
0.9884
+0.0119 (1.22%)
After-hours: Oct 30, 2026, 7:40 PM EDT
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
12.95M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bolt Biotherapeutics | 4.70M |
| Cerenome | 4.20M |
| Dyadic International | 3.80M |
| Daré Bioscience | 1.37M |
| Allarity Therapeutics | 345.00K |
| aTyr Pharma | 190.00K |
| Vyome Holdings | 129.73K |
| BioCardia | 3.00K |
GUTS News
- 2 days ago - Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization - GlobeNewsWire
- 3 days ago - Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 10 days ago - Fractyl Health cuts about 45% of workforce to focus on Revita - TheFly
- 10 days ago - Fractyl Health ends Rejuva development, sees cash runway into Q2 2027 - TheFly
- 10 days ago - Fractyl Health co-founder Jay Caplan to retire, continue as advisor - TheFly
- 10 days ago - Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 12 days ago - Fractyl Health price target lowered to $39 from $96 at Canaccord - TheFly
- 13 days ago - Fractyl Health price target lowered to $5 from $48 at Craig-Hallum - TheFly